New Treatments in Chronic Liver Disease 2027 CME Course - San Diego, CA

Memo

New Treatments in Chronic Liver Disease will highlight the latest advancements in medications and therapies for liver care and transplantation. The program will offer an in-depth review of clinical trials and real-world data on oral treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. This annual CME conference delivers a comprehensive yet targeted program designed to provide physicians with the latest updates and practical insights for managing liver diseases.Educational ObjectivesUpon completion of this activity, participants should be able to:- Cite new strategies for identifying and managing metabolic liver disease.- Review updated goals and guidelines for curing Delta Hepatitis, HBV and HCV.- Discuss potential new treatments for alcohol-related liver disease.- Summarize novel markers and therapies in PBC and PSC.- Evaluate liver masses and new therapeutic options for HCC.- Employ strategies for treating and managing ascites and hepatorenal syndrome.Date and Time: On Saturday March 13, 2027 at 7:00 am to Sunday March 14, 2027 at 12:00 pmVenue details: The Seabird Ocean Resort and Spa, a Destination by Hyatt Hotel, 101 Mission Avenue, Oceanside, California, 92054, United StatesPrices:Physicians (MD, DO, MBBS): USD 375.00,RN, NP, PA, Others: USD 275.00,Students, Residents, Fellows: USD 175.00